Publication | Closed Access

Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways

Breast OncologyEndocrine-related CancerMedicineApoptosisCell DeathBreast CancerDifferent Glycolytic AttitudeAnti-cancer AgentPharmacologyCell BiologyCancer ResearchDistinct Signaling Pathways